{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:24:53Z","timestamp":1791944693732,"version":"4.3.4"},"reference-count":84,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"abstract":"<jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Secondary hyperparathyroidism (SHPT) is a challenge frequently encountered in the management of patients with chronic kidney disease (CKD). Downregulation of the parathyroid vitamin D and calcium-sensing receptors represent critical steps that lead to abnormalities in mineral metabolism: high phosphate, low calcium, and vitamin D deficiency. These imbalances result in parathyroid hyperplasia and contribute to vascular calcification. New studies have established a central role for fibroblast growth factor 23 (FGF-23) in the regulation of phosphate-vitamin D homeostasis. FGF-23 concentration increases in CKD and contributes to SHPT. Achieving current targets for the key mineral parameters in the management of SHPT set by the Kidney Disease Improving Global Outcomes (KDIGO) guidelines can be challenging. This review summarizes the current understanding and evidence supporting strategies for SHPT treatment in CKD patients. Treatment should include a combination of dietary phosphorus restriction, phosphate binders, vitamin D sterols, and calcimimetics. Parathyroidectomy is effective in suitable candidates refractory to medical therapy and the standard against which new approaches should be measured. Future strategies may focus on the stimulation of apoptotic activity of hyperplastic parathyroid cells.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.06040710","type":"journal-article","created":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:09:53Z","timestamp":1301616593000},"page":"913-921","source":"Crossref","is-referenced-by-count":526,"title":["Secondary Hyperparathyroidism"],"prefix":"10.2215","volume":"6","author":[{"given":"John","family":"Cunningham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-32-20230811","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1046\/j.1523-1755.1999.07304.x","article-title":"Pathogenesis of secondary hyperparathyroidism","volume":"73","author":"Slatopolsky","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"R2-32-20230811","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/BF01479995","article-title":"Role of parathyroid hormone in the pathogenesis of the uremic manifestations","volume":"57","author":"Massry","year":"1979","journal-title":"Klin Wochenschr"},{"key":"R3-32-20230811","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1525-139X.2009.00581.x","article-title":"Parathyroid hormone: A uremic toxin","volume":"22","author":"Rodriguez","year":"2009","journal-title":"Semin Dial"},{"key":"R4-32-20230811","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1046\/j.1523-1755.1999.00386.x","article-title":"Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: Role of dietary phosphate","volume":"55","author":"Brown","year":"1999","journal-title":"Kidney Int"},{"key":"R5-32-20230811","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1523-1755.2003.00056.x","article-title":"Autoregulation in the parathyroid glands by PTH\/PTHrP receptor ligands in normal and uremic rats","volume":"64","author":"Lewin","year":"2003","journal-title":"Kidney Int"},{"key":"R7-32-20230811","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1097\/01.ASN.0000141016.20133.33","article-title":"Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency","volume":"15","author":"Mizobuchi","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R8-32-20230811","doi-asserted-by":"crossref","first-page":"F253","DOI":"10.1152\/ajprenal.00302.2004","article-title":"The calcium-sensing receptor: A key factor in the pathogenesis of secondary hyperparathyroidism","volume":"288","author":"Rodriguez","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"R9-32-20230811","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00774-005-0665-9","article-title":"Regulation of parathyroid function in chronic renal failure","volume":"24","author":"Rodriguez","year":"2006","journal-title":"J Bone Miner Metab"},{"key":"R10-32-20230811","doi-asserted-by":"crossref","first-page":"F605","DOI":"10.1152\/ajprenal.90272.2008","article-title":"Direct upregulation of parathyroid calcium-sensing receptor and vitamin D receptor by calcimimetics in uremic rats","volume":"296","author":"Mendoza","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"R11-32-20230811","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J Clin Invest"},{"key":"R12-32-20230811","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/ki.2009.464","article-title":"Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease","volume":"77","author":"Galitzer","year":"2010","journal-title":"Kidney Int"},{"key":"R13-32-20230811","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ki.2009.414","article-title":"Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients","volume":"77","author":"Komaba","year":"2010","journal-title":"Kidney Int"},{"key":"R14-32-20230811","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ki.2009.466","article-title":"FGF23-parathyroid interaction: Implications in chronic kidney disease","volume":"77","author":"Komaba","year":"2010","journal-title":"Kidney Int"},{"key":"R15-32-20230811","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ki.2009.512","article-title":"Does the downregulation of the FGF23 signaling pathway in hyperplastic parathyroid glands contribute to refractory secondary hyperparathyroidism in CKD patients?","volume":"77","author":"Lafage-Proust","year":"2010","journal-title":"Kidney Int"},{"key":"R16-32-20230811","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1681\/ASN.2009040427","article-title":"FGF23 fails to inhibit uremic parathyroid glands","volume":"21","author":"Canalejo","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R17-32-20230811","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1523-1755.2005.00184.x","article-title":"Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients","volume":"67","author":"Nakanishi","year":"2005","journal-title":"Kidney Int"},{"key":"R18-32-20230811","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1523-1755.2005.00178.x","article-title":"Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients","volume":"67","author":"Kazama","year":"2005","journal-title":"Kidney Int"},{"key":"R19-32-20230811","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1210\/endo.139.10.6262","article-title":"Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice","volume":"139","author":"Li","year":"1998","journal-title":"Endocrinology"},{"key":"R20-32-20230811","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/ndt\/gfm177","article-title":"Can calcimimetics inhibit parathyroid hyperplasia? Evidence from preclinical studies","volume":"22","author":"Drueke","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R21-32-20230811","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1097\/01.ASN.0000024439.38838.03","article-title":"Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation","volume":"13","author":"Lewin","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R22-32-20230811","doi-asserted-by":"crossref","first-page":"F1192","DOI":"10.1152\/ajprenal.00360.2009","article-title":"Deletion of the vitamin D receptor specifically in the parathyroid demonstrates a limited role for the receptor in parathyroid physiology","volume":"297","author":"Meir","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"R23-32-20230811","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1093\/ndt\/gfn438","article-title":"PTH, FGF-23 and early CKD","volume":"23","author":"Rodriguez","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R24-32-20230811","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2007060673","article-title":"Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD","volume":"19","author":"Isakova","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R25-32-20230811","doi-asserted-by":"crossref","first-page":"11085","DOI":"10.1073\/pnas.0704446104","article-title":"Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption","volume":"104","author":"Berndt","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R26-32-20230811","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/ndt\/gfp616","article-title":"Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate","volume":"25","author":"Canalejo","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R27-32-20230811","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00041552-199607000-00008","article-title":"Molecular genetics of hyperparathyroid disease","volume":"5","author":"Tominaga","year":"1996","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R28-32-20230811","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1681\/ASN.V1161141","article-title":"Cell biology of parathyroid gland hyperplasia in chronic renal failure","volume":"11","author":"Drueke","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R29-32-20230811","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.ki.5002287","article-title":"Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics","volume":"74","author":"Goodman","year":"2008","journal-title":"Kidney Int"},{"key":"R30-32-20230811","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1046\/j.1523-1755.2001.00027.x","article-title":"Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor","volume":"60","author":"Ritter","year":"2001","journal-title":"Kidney Int"},{"key":"R31-32-20230811","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.ki.5002675","article-title":"The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats","volume":"73","author":"Lopez","year":"2008","journal-title":"Kidney Int"},{"key":"R32-32-20230811","doi-asserted-by":"crossref","first-page":"F1390","DOI":"10.1152\/ajprenal.00262.2006","article-title":"The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands","volume":"292","author":"Rodriguez","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"R33-32-20230811","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1097\/01.ASN.0000037676.54018.CB","article-title":"Regulation of parathyroid vitamin D receptor expression by extracellular calcium","volume":"13","author":"Garfia","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R34-32-20230811","doi-asserted-by":"crossref","first-page":"F1197","DOI":"10.1152\/ajprenal.00529.2009","article-title":"The up-regulation of the parathyroid VDR expression by extracellular calcium is mediated by the ERK1\/2-MAPK signaling pathway","volume":"298","author":"Canadillas","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"R35-32-20230811","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1681\/ASN.2004080657","article-title":"Calcium-sensing receptor expression and parathyroid hormone secretion in hyperplastic parathyroid glands from humans","volume":"16","author":"Canadillas","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R36-32-20230811","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.RES.0000141775.67189.98","article-title":"Pathophysiology of vascular calcification in chronic kidney disease","volume":"95","author":"Moe","year":"2004","journal-title":"Circ Res"},{"key":"R37-32-20230811","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1681\/ASN.2007080854","article-title":"Mechanisms of vascular calcification in chronic kidney disease","volume":"19","author":"Moe","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R38-32-20230811","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.ki.5002059","article-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","volume":"71","author":"Block","year":"2007","journal-title":"Kidney Int"},{"key":"R39-32-20230811","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.mnh.0000172719.26606.6f","article-title":"Fetuin-A and extraosseous calcification in uremia","volume":"14","author":"Ketteler","year":"2005","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R40-32-20230811","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","article-title":"The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: The Heart and Soul Study","volume":"152","author":"Parker","year":"2010","journal-title":"Ann Intern Med"},{"key":"R43-32-20230811","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000073945","article-title":"Management of secondary hyperparathyroidism: The importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product","volume":"23","author":"Moe","year":"2003","journal-title":"Am J Nephrol"},{"key":"R44-32-20230811","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/ndt\/17.suppl_10.10","article-title":"Vitamin D analogues for secondary hyperparathyroidism","volume":"17","author":"Brown","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"R45-32-20230811","first-page":"E488","article-title":"Intestinal Ca and phosphate transport: Differential responses to vitamin D3 metabolites","volume":"233","author":"Walling","year":"1977","journal-title":"Am J Physiol"},{"key":"R46-32-20230811","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/MOL.0b013e328011c6fc","article-title":"Vitamin D and vascular calcification","volume":"18","author":"Zittermann","year":"2007","journal-title":"Curr Opin Lipidol"},{"key":"R47-32-20230811","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1046\/j.1523-1755.2003.00878.x","article-title":"Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism","volume":"63","author":"Sprague","year":"2003","journal-title":"Kidney Int"},{"key":"R48-32-20230811","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ki.1989.89","article-title":"1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia","volume":"35","author":"Szabo","year":"1989","journal-title":"Kidney Int"},{"key":"R49-32-20230811","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1681\/ASN.V11101865","article-title":"The in vitro effect of calcitriol on parathyroid cell proliferation and apoptosis","volume":"11","author":"Canalejo","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R50-32-20230811","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJM199008093230617","article-title":"Regression of parathyroid hyperplasia by calcitriol-pulse therapy in patients on long-term dialysis","volume":"323","author":"Fukagawa","year":"1990","journal-title":"N Engl J Med"},{"key":"R51-32-20230811","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1523-1755.1999.00538.x","article-title":"Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient","volume":"56","author":"Rodriguez","year":"1999","journal-title":"Kidney Int"},{"key":"R52-32-20230811","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1172\/JCI118061","article-title":"Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins","volume":"96","author":"Patel","year":"1995","journal-title":"J Clin Invest"},{"key":"R53-32-20230811","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000188261","article-title":"Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients","volume":"68","author":"Fukagawa","year":"1994","journal-title":"Nephron"},{"key":"R54-32-20230811","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s002689900113","article-title":"Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism","volume":"20","author":"Tominaga","year":"1996","journal-title":"World J Surg"},{"key":"R55-32-20230811","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1172\/JCI116720","article-title":"Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients","volume":"92","author":"Fukuda","year":"1993","journal-title":"J Clin Invest"},{"key":"R56-32-20230811","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1152\/ajpendo.00224.2004","article-title":"Cardiac hypertrophy in vitamin D receptor knockout mice: Role of the systemic and cardiac renin-angiotensin systems","volume":"288","author":"Xiang","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R57-32-20230811","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jsbmb.2006.12.098","article-title":"Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse","volume":"103","author":"Simpson","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R58-32-20230811","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ki.2008.101","article-title":"Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice","volume":"74","author":"Zhou","year":"2008","journal-title":"Kidney Int"},{"key":"R59-32-20230811","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: A historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R60-32-20230811","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/sj.ki.5001868","article-title":"Mortality risk among hemodialysis patients receiving different vitamin D analogs","volume":"70","author":"Tentori","year":"2006","journal-title":"Kidney Int"},{"key":"R61-32-20230811","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"key":"R62-32-20230811","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/ki.2008.343","article-title":"Oral active vitamin D is associated with improved survival in hemodialysis patients","volume":"74","author":"Naves-Diaz","year":"2008","journal-title":"Kidney Int"},{"key":"R63-32-20230811","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1053\/ajkd.1998.v32.pm9808143","article-title":"Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-nor-1,25-dihydroxyvitamin D2","volume":"32","author":"Llach","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"R64-32-20230811","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0272-6386(12)80059-X","article-title":"Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy","volume":"16","author":"Meric","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"R65-32-20230811","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0272-6386(99)70221-0","article-title":"A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients","volume":"33","author":"Bleyer","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R66-32-20230811","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.103.057273","article-title":"Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl","volume":"308","author":"Nemeth","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"R67-32-20230811","first-page":"i29","article-title":"Clinical outcomes in secondary hyperparathyroidism and the role of calcimimetics","volume":"1","author":"Cunningham","year":"2008","journal-title":"NDT Plus"},{"key":"R68-32-20230811","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1681\/ASN.2007121320","article-title":"Cinacalcet reduces the set point of the PTH-calcium curve","volume":"19","author":"Valle","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R69-32-20230811","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/ndt\/gfh966","article-title":"Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl","volume":"20","author":"Moe","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R70-32-20230811","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2215\/CJN.01040308","article-title":"Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: The ACHIEVE study results","volume":"3","author":"Fishbane","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R71-32-20230811","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2215\/CJN.03630509","article-title":"Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD","volume":"5","author":"Wetmore","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R72-32-20230811","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1523-1755.2005.67103.x","article-title":"Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism","volume":"67","author":"Colloton","year":"2005","journal-title":"Kidney Int"},{"key":"R73-32-20230811","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00041552-199307000-00004","article-title":"Mechanisms underlying the regulation of parathyroid hormone secretion in vivo and in vitro","volume":"2","author":"Brown","year":"1993","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R74-32-20230811","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1523-1755.1998.00782.x","article-title":"NPS R-568 halts or reverses osteitis fibrosa in uremic rats","volume":"53","author":"Wada","year":"1998","journal-title":"Kidney Int"},{"key":"R75-32-20230811","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1741-7007-7-17","article-title":"The calcium-sensing receptor regulates parathyroid hormone gene expression in transfected HEK293 cells","volume":"7","author":"Galitzer","year":"2009","journal-title":"BMC Biol"},{"key":"R76-32-20230811","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2215\/CJN.02110310","article-title":"Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism","volume":"5","author":"Komaba","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R77-32-20230811","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/ndt\/gfn654","article-title":"Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism","volume":"24","author":"Meola","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R78-32-20230811","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R79-32-20230811","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1093\/ndt\/gfn026","article-title":"Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism","volume":"23","author":"Block","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R81-32-20230811","first-page":"iii557","article-title":"Comparison of cardiovascular calcium scoring methods in the advance study","volume":"3","author":"Raggi","year":"2010","journal-title":"NDT Plus"},{"key":"R82-32-20230811","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/ndt\/gfp762","article-title":"Study design and subject baseline characteristics in the ADVANCE Study: Effects of cinacalcet on vascular calcification in haemodialysis patients","volume":"25","author":"Floege","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R83-32-20230811","doi-asserted-by":"crossref","first-page":"iii31","DOI":"10.1093\/ndt\/gfg1008","article-title":"Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients","volume":"18","author":"Fukagawa","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R84-32-20230811","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/sj.ki.5001596","article-title":"Direct injection of calcitriol or its analog into hyperplastic parathyroid glands induces apoptosis of parathyroid cells","volume":"102","author":"Shiizaki","year":"2006","journal-title":"Kidney Int Suppl"},{"key":"R85-32-20230811","doi-asserted-by":"crossref","first-page":"iii47","DOI":"10.1093\/ndt\/gfg1012","article-title":"Efficacy of direct injection of calcitriol into the parathyroid glands in uraemic patients with moderate to severe secondary hyperparathyroidism","volume":"18","author":"Nakanishi","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R86-32-20230811","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2215\/CJN.04150907","article-title":"Does vitamin D receptor and calcium receptor activation therapy play a role in the histopathologic alterations of parathyroid glands in refractory uremic hyperparathyroidism?","volume":"3","author":"Lomonte","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R87-32-20230811","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1111\/j.1744-9987.2008.00627.x","article-title":"Parathyroidectomy for secondary hyperparathyroidism in the era of calcimimetics","volume":"12","author":"Tominaga","year":"2008","journal-title":"Ther Apher Dial"},{"key":"R88-32-20230811","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1007\/s00268-009-0086-3","article-title":"Endoscopic total parathyroidectomy and partial parathyroid tissue autotransplantation for patients with secondary hyperparathyroidism: A new surgical approach","volume":"33","author":"Sun","year":"2009","journal-title":"World J Surg"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201104000-00032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:40:42Z","timestamp":1786369242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201104000-00032"}},"subtitle":["Pathogenesis, Disease Progression, and Therapeutic Options"],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":84,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.06040710","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}